Enrolling by invitationNCT06969586
The Effect of Topical Rho-kinase Inhibitors on Corneas of Patients With Fuchs Endothelial Corneal Dystrophy
Studying Congenital glaucoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital Dubrava
- Principal Investigator
- Josip Pavan, prof.dr.sc.University Hospital Dubrava
- Intervention
- Netarsudil 0.02% Ophthalmic Solution(drug)
- Enrollment
- 50 enrolled
- Eligibility
- 40-90 years · All sexes
- Timeline
- 2025 – 2026
Study locations (1)
- University Hospital Dubrava, Zagreb, Croatia
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06969586 on ClinicalTrials.govOther trials for Congenital glaucoma
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNANCT06837610Inverted T Trabeculectomy Primary Congenital GlaucomaBenha University
- RECRUITINGNANCT04129021High Resolution, High-speed Multimodal Ophthalmic ImagingCentre Hospitalier National d'Ophtalmologie des Quinze-Vingts
- RECRUITINGNCT02014389Evaluation of Objective Perimetry Using Chromatic Multifocal PupillometerSheba Medical Center